K. Sternberg

Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open‐label, single‐arm, multicenter clinical study

Vjera Holthoff, Frank Tennigkeit, Serge Gauthier, 2013, International journal of geriatric psychiatry.

IncobotulinumtoxinA for the Treatment of Blepharospasm in Toxin-Naïve Subjects: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial

D. Mitsikostas, A. Dekundy, M. Althaus, 2020, Advances in Therapy.

Patient-reported outcomes in the context of the benefit assessment in Germany

Christoph Gerlinger, Kati Sternberg, Friedhelm Leverkus, 2021, 2107.03249.

Sustained effects of once-daily memantine treatment on cognition and functional communication skills in patients with moderate to severe Alzheimer's disease: results of a 16-week open-label trial.

A. Kurz, F. Tennigkeit, J. Schulz, 2011, Journal of Alzheimer's disease : JAD.

Validation of the relevant outcome scale for Alzheimer's disease: a novel multidomain assessment for daily medical practice

Frank Tennigkeit, Serge Gauthier, Kati Sternberg, 2011, Alzheimer's Research & Therapy.